MAPK3 and CX3CL1 were strongly positive; NFE2L2, HSP90AB1, and SUPT20H were moderately positive; and FKBP1B, BIRC5, NPC1, IKBKE, BID, and PTEN were weakly positive in glioma tissue relative to their expression levels in normal tissue (Supplementary Figures S1A–K). This evidence concerns the gene NFE2L2 and central nervous system cancer.